High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption

被引:1
|
作者
Drouin-Chartier, Jean-Philippe [1 ,2 ,3 ]
Tremblay, Andre J. [1 ]
Bergeron, Jean [2 ,3 ]
Lamarche, Benoit [4 ]
Couture, Patrick [1 ,2 ,3 ]
机构
[1] Laval Univ, Dept Med, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
[2] Laval Univ, CHU Quebec, Dept Med, Lipid Clin, Quebec City, PQ, Canada
[3] Laval Univ, CHU Quebec, Dept Med, Lipid Res Ctr, Quebec City, PQ, Canada
[4] Laval Univ, Sch Nutr, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Homozygous familial hypercholesterolemia; Lipoprotein apheresis; Dextran sulfate adsorption; Triglyceride; LDL-Cholesterol; CORONARY-HEART-DISEASE; LDL RECEPTOR GENE; CARDIOVASCULAR-DISEASE; FRIEDEWALD FORMULA; CHOLESTEROL; PLASMA; MUTATION; HYPERLIPOPROTEINEMIA; APOLIPOPROTEIN(A); POPULATION;
D O I
10.1016/j.atherosclerosis.2018.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Maximizing the acute reduction of LDL-cholesterol (C) and lipoprotein (a) (Lp(a)) concentrations in patients with homozygous familial hypercholesterolemia (HoFH) is the main goal of lipoprotein apheresis (LA). The objective of this study was to examine how the pre-LA serum TG concentrations influence the efficacy of LA to acutely reduce LDL-C and Lp(a) concentrations in HoFH patients. Methods: Data from 1761 LA treatments of HoFH patients (n = 10) and compound heterozygous patients (n = 5) collected between 2008 and 2016 were analyzed. These data included the pre-and post-LA concentrations of LDL-C, TGs and Lp(a); volume of filtered plasma; type of LA system used (dextran sulfate adsorption (DSA) or heparin-induced extracorporeal LDL precipitation (HELP)); and interval between treatments. Results: A significant association between the pre-LA TG concentrations and acute LA-induced reduction in LDL-C, modified by the type of LA system used, was observed (p pre-LA TG quartile*LA system =.04). Using the DSA system, the acute reduction of the LDL-C concentrations was attenuated by 3.9% when the preLA TG concentrations were > 2.09 mmol/L vs. <= 0.93 mmol/L (highest vs. lowest quartiles: =59.4% vs. =63.3%, p =.007). Using the HELP system, no significant difference was observed in the reduction of LDL-C between the highest and the lowest quartiles of serum TGs (=65.8% vs. =66.4%, p =.9). No association was observed between pre-LA TG concentrations and acute LA-induced decrease in Lp(a) (p =.2). Conclusions: The efficacy of LA is inversely associated with pre-LA TG concentrations in HoFH patients who used the DSA system instead of the HELP system. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [1] PREGNANCY IN A PATIENT WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA UNDERGOING LOW-DENSITY-LIPOPROTEIN APHERESIS BY DEXTRAN SULFATE ADSORPTION
    TERUEL, JL
    LASUNCION, MA
    NAVARRO, JF
    CARRERO, P
    ORTUNO, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (07): : 929 - 933
  • [2] Impact of lipoprotein apheresis with dextran-sulfate adsorption on the expression of genes involved in cardiovascular health in the blood of patients with homozygous familial hypercholesterolemia
    Drouin-Chartier, Jean-Philippe
    Tremblay, Andre J.
    Bergeron, Jean
    Laflamme, Nathalie
    Lamarche, Benoit
    Couture, Patrick
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (01) : 104 - 107
  • [3] Low Density Lipoprotein Apheresis in Pediatric Patients With Homozygous Familial Hypercholesterolemia
    Coker, Mahmut
    Ucar, Sema Kalkan
    Simsek, Damla Goksen
    Darcan, Sukran
    Bak, Mustafa
    Can, Sule
    THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (02) : 121 - 128
  • [4] Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review
    Luirink, Ilse K.
    Determeijer, Jim
    Hutten, Barbara A.
    Wiegman, Albert
    Bruckert, Eric
    Schmitt, Claus P.
    Groothoff, Jaap W.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (01) : 31 - 39
  • [5] REDUCTION OF LIPOPROTEIN(A) BY LDL-APHERESIS USING A DEXTRAN SULFATE CELLULOSE COLUMN IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    KOIZUMI, J
    KOIZUMI, I
    UNO, Y
    INAZU, A
    KAJINAMI, K
    HARAKI, T
    YAGI, K
    KAMON, N
    MIYAMOTO, S
    TAKEGOSHI, T
    MABUCHI, H
    TAKEDA, R
    TANI, N
    TAKADA, S
    ATHEROSCLEROSIS, 1993, 100 (01) : 65 - 74
  • [6] Low Density Lipoprotein Apheresis in Lebanese Pediatric Patients with Homozygous Familial Hypercholesterolemia
    Mourani, C. C.
    Hneidi, M.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1943 - 1943
  • [7] Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia
    Duell, Paul Barton
    Warden, Bruce A. A.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 : 12 - 17
  • [8] TREATMENT OF REFRACTORY FAMILIAL HYPERCHOLESTEROLEMIA BY LOW-DENSITY-LIPOPROTEIN APHERESIS USING AN AUTOMATED DEXTRAN SULFATE CELLULOSE ADSORPTION SYSTEM
    GORDON, BR
    KELSEY, SF
    BILHEIMER, DW
    BROWN, DC
    DAU, PC
    GOTTO, AM
    ILLINGWORTH, DR
    JONES, PH
    LEITMAN, SF
    PRIHODA, JS
    STEIN, EA
    STERN, TN
    ZAVORAL, JH
    ZWIENER, RJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (11): : 1010 - 1016
  • [9] SERUM LIPOPROTEIN-(A) LEVELS UNDER LDL-APHERESIS TREATMENT IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    LASUNCION, MA
    TERUEL, JL
    ALVAREZ, JJ
    GOMEZCORONADO, D
    ORTUNO, J
    HERRERA, E
    MEDICINA CLINICA, 1992, 99 (14): : 541 - 544
  • [10] IMPACT OF LIPOPROTEIN APHERESIS ON SERUM MYELOPEROXIDASE LEVELS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Sehar, N.
    Moriarty, P. M.
    ATHEROSCLEROSIS, 2015, 241 (01) : E200 - E200